Steven Cohen's OVID Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.95 M shares of Ovid Therapeutics Inc. (OVID) worth $5.23 M, representing 0.01% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Steven Cohen has maintained this position in OVID for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 625,117 shares. Largest reduction occurred in Q1 2026, reducing 2.23 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Ovid Therapeutics (OVID) Holding Value Over Time
Track share changes against reported price movement
Quarterly Ovid Therapeutics (OVID) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +625,117 | Add 47.34% | 1.95 M | $2.69 |
| Q1 2026 | -2.23 M | Reduce 62.81% | 1.32 M | $2.22 |
| Q4 2025 | +3.55 M | New Buy | 3.55 M | $1.63 |
Steven Cohen's Ovid Therapeutics Investment FAQs
Steven Cohen first purchased Ovid Therapeutics Inc. (OVID) in Q4 2025, acquiring 3,551,129 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Ovid Therapeutics Inc. (OVID) for 3 quarters since Q4 2025.
Steven Cohen's largest addition to Ovid Therapeutics Inc. (OVID) was in Q4 2025, adding 3,551,129 shares worth $5.79 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,945,727 shares of Ovid Therapeutics Inc. (OVID), valued at approximately $5.23 M.
As of the Q2 2026 filing, Ovid Therapeutics Inc. (OVID) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Ovid Therapeutics Inc. (OVID) was 3,551,129 shares, as reported at the end of Q4 2025.